Spear Phishing Incident Response Checklist for Lab Results Interface Engines

A spear phishing incident can put more than an email account at risk. If an attacker gains access to a laboratory worker’s credentials or workstation, they may reach the laboratory information system (LIS), interface engine, electronic health record (EHR), or the services that transmit results between them.

Use this checklist to coordinate cybersecurity response with laboratory, clinical, privacy, and IT teams. Prioritize patient safety, preserve evidence where feasible, and avoid replaying or changing result messages until the appropriate technical and clinical owners have assessed the risk.

How to scope the incident and preserve evidence

Assign an incident lead and a clinical operations contact. Record the initial report, the suspected phishing message, affected users, known actions taken, and a timeline using a consistent time zone. Involve privacy, legal, laboratory leadership, and relevant vendors according to your organization’s incident plan.

Establish the likely entry point and scope. Determine who received, opened, or interacted with the message; whether credentials or multi-factor authentication were submitted; which devices were used; and whether the account accessed email, remote access, the identity provider, LIS, EHR, or interface-engine administration tools. Check for shared, privileged, vendor, and service accounts that may have been exposed.

• Preserve the original email, including full headers, attachments, URLs, and delivery details. Record whether it was reported, quarantined, or deleted.
• Secure relevant identity-provider sign-in records, authentication events, endpoint alerts, VPN records, email audit logs, and administrative activity.
• Export relevant HL7 interface engine audit logs, message queues, routing or transformation changes, acknowledgments, error logs, and connection records. Preserve logs from both sending and receiving systems when available.
• Record the systems’ clock settings and any known time differences. Maintain an evidence log showing who collected, transferred, or accessed each item and when.
• Preserve suspicious files and messages in a controlled location. Avoid opening attachments or clicking links during the investigation.

When possible, collect logs and other volatile evidence before making changes, but do not delay urgent containment if an attacker appears active or patient care is at risk. Coordinate forensic collection with qualified responders and follow organizational legal and privacy procedures. NIST SP 800-86 describes forensic evidence collection and handling, while NIST SP 800-61 Rev. 3 provides current incident-response recommendations.

Which accounts and endpoints should be contained first?

Contain accounts and devices based on evidence of compromise, access level, and potential effect on patient care. If an account is actively being misused, block or suspend it promptly through approved identity-management procedures. Change its credentials from a trusted device and revoke active sessions, refresh tokens, and other access mechanisms where your identity platform supports it.

• Start with exposed privileged accounts. Prioritize identity, email, remote access, LIS, EHR, interface-engine, and infrastructure administrators, along with accounts able to change routes or result mappings.
• Contain affected user accounts. Include laboratory staff and clinicians whose credentials may have been phished or used from unusual devices or locations.
• Review service and vendor access. Investigate accounts, API credentials, certificates, and integrations that may have been accessed or modified. Coordinate changes with system owners so containment does not silently interrupt a critical workflow.
• Isolate suspect endpoints. Use endpoint security tools or network controls to disconnect a compromised workstation from the network while preserving evidence when feasible. Do not wipe or reimage it before evidence collection unless patient safety or immediate containment requires it.

Include identity session and token revocation in the response; changing a password alone may not end existing sessions. Review recently granted permissions, new authentication methods, application consents, administrator-role changes, and unusual access to clinical systems. Microsoft’s guidance, for Microsoft 365 environments specifically, explains how to revoke sessions and investigate compromised accounts; apply the equivalent process for your own platforms. Microsoft’s compromised-account response guidance

Containment decisions should account for service availability as well as evidence preservation. Coordinate any shutdown, network isolation, or access restriction affecting laboratory testing or result delivery with laboratory and clinical leaders. NIST’s incident-handling guidance identifies evidence preservation and service availability as factors in choosing a containment strategy.

How to identify and block malicious indicators

Use the phishing email and the affected accounts’ activity to identify indicators that can be searched across the environment. Depending on what the investigation finds, indicators may include sender addresses, domains, URLs, attachment hashes, source IP addresses, device identifiers, suspicious sign-in patterns, and unauthorized changes to accounts or systems.

• Search mailboxes and mail-flow records for related messages, lookalike senders, replies, and internal forwarding.
• Check affected mailboxes and administrative mail-flow settings for unfamiliar rules, redirects, forwarding destinations, or rules that move or delete messages. This mailbox forwarding rule investigation can help identify persistence or possible disclosure.
• Search identity, endpoint, network, and application logs for activity associated with affected accounts, devices, IPs, and time ranges. Look for access to LIS, EHR, interface-engine consoles, shared folders, or result-export functions.
• Block confirmed malicious domains, URLs, senders, or files using controls that fit your environment. Check whether a broad block could disrupt a legitimate laboratory vendor or clinical connection before applying it.
• Expand the search when an indicator appears in another account or system. A single compromised mailbox may not represent the full scope.

Preserve the relevant messages, rule settings, and audit events before removing malicious rules or deleting artifacts when feasible. Then remove confirmed unauthorized forwarding or access changes, and document what was changed and when. Microsoft’s documentation provides examples of reviewing forwarding settings and inbox rules in Microsoft 365; other platforms require their own administrative procedures. Microsoft’s guidance for investigating and restoring a compromised mailbox

How to assess impact on laboratory systems and result integrity

Determine whether the incident involved only email or extended into systems that create, transform, route, store, or display laboratory results. Review access and change records for the LIS, interface engine, EHR, middleware, database, and connected laboratory instruments or vendor services. Pay particular attention to changes in user permissions, result-routing destinations, interface filters, transformation logic, and configuration.

Assess confidentiality, integrity, and availability separately. Consider whether patient information may have been accessed or disclosed, whether results or related identifiers may have been altered or suppressed, and whether messages were delayed, duplicated, rejected, or misrouted. The HIPAA Security Rule requires covered entities and business associates to protect the confidentiality, integrity, and availability of electronic protected health information and to maintain appropriate audit controls. HHS’s HIPAA Security Rule summary

To evaluate electronic health record (EHR) result integrity, compare records across systems rather than relying on a single screen or log. With laboratory and interface-engine specialists, reconcile the source LIS result against the outbound message, interface-engine processing record, receiving-system acknowledgment, and EHR result as available. Check patient and specimen identifiers, accession numbers, test codes, values, units, reference ranges, abnormal flags, timestamps, and amendments. The precise fields and logs available vary by system and implementation.

• Identify the affected time window and message types, including messages still queued or awaiting acknowledgment.
• Look for missing, repeated, delayed, rejected, or unexpected messages, and investigate unexplained queue reprocessing or route changes.
• Compare source records and downstream results for discrepancies. Have authorized laboratory personnel determine whether clinical review or correction is needed.
• Preserve message identifiers, timestamps, acknowledgments, and relevant before-and-after configuration records to support reconciliation.

Do not assume that a successful transmission acknowledgment proves that the clinical content was correct, or that a lack of detected changes proves that every result is unaffected. Treat uncertain results as unresolved until the appropriate laboratory and clinical owners complete a documented review.

Separately, have the privacy or compliance team assess whether PHI may have been impermissibly accessed or disclosed. For HIPAA-regulated organizations, HHS explains that the Breach Notification Rule generally requires a risk assessment when determining whether an impermissible use or disclosure compromised PHI, unless an applicable exception or notification decision applies. HHS’s Breach Notification Rule guidance

How to maintain patient-care continuity during response

Activate the organization’s clinical system downtime procedures when the incident disrupts reliable access to results, safe result delivery, or a system needed for timely clinical decisions. The decision should be made with laboratory and clinical leadership based on operational impact—not solely on whether a cyber incident has been declared.

• Use approved downtime workflows for ordering, specimen identification, result reporting, escalation of critical values, and documentation.
• Communicate which systems and result pathways are unavailable or under review, who is authorized to provide updates, and how staff should escalate urgent patient-care needs.
• Use only organization-approved alternative communication and documentation methods. Protect patient information and preserve a record of actions for later reconciliation.
• Track specimens, results, pending messages, manual reports, and any results that require entry or confirmation after systems return.
• Keep the response team informed of clinical constraints before isolating or restarting systems that support testing or result delivery.

The HIPAA Security Rule requires regulated entities to establish contingency procedures that address emergencies affecting systems containing ePHI, including data backup, recovery, and continuation of critical processes in emergency mode. It does not prescribe one universal clinical downtime workflow; organizations should follow their own tested plans and applicable policies. HHS’s summary of HIPAA contingency-plan requirements

How to restore systems and validate laboratory results

Restore only after the incident team has addressed the suspected access path, confirmed that the systems and recovery sources are suitable for use, and coordinated the plan with laboratory and clinical owners. Use a verified backup restoration process: confirm backup provenance and integrity, select a recovery point appropriate to the incident, and restore into a controlled environment where possible before reconnecting affected services.

HHS recommends periodically testing backup restoration to verify the integrity of backed-up data and confidence in recovery capability. A successful data restore by itself does not establish that interface routes, mappings, credentials, or patient results are correct; validate these separately with the system owners. HHS guidance on ransomware and HIPAA contingency planning

• Confirm the restored LIS, interface engine, EHR connections, queues, routes, permissions, and relevant security controls against trusted configuration records.
• Test interfaces using approved procedures and controlled test data before resuming normal production flows.
• Reconcile messages processed during the incident and downtime. Check for missing or duplicate results, unresolved queues, delayed messages, and any manual reports requiring entry or confirmation.
• Have authorized laboratory and clinical personnel review results or time periods identified as potentially affected. Document discrepancies, corrections, notifications, and sign-off.
• Monitor authentication, administrative changes, interface activity, and result delivery closely after recovery. Retain incident records and use findings to improve response and downtime plans.

In summary, a safe response connects cybersecurity containment with laboratory reconciliation and clinical decision-making. Preserve evidence, secure exposed access, investigate message and result pathways, maintain care through approved downtime procedures, and return systems to service only after technical and clinical validation.

FAQs

What evidence should be preserved during a spear phishing incident?

Preserve the original phishing email and full headers, attachments and URLs, relevant email and identity logs, endpoint and network records, account and permission changes, and LIS, EHR, and interface-engine audit logs. Document collection times, handlers, transfers, and actions taken. Protect evidence from alteration and follow your organization’s forensic, privacy, and legal procedures.

How should compromised accounts and endpoints be contained?

Prioritize actively misused and privileged accounts, including access to email, identity services, remote access, LIS, EHR, and interface-engine administration. Block or suspend compromised accounts, reset credentials from a trusted device, revoke active sessions and tokens, and remove unauthorized access changes. Isolate suspect endpoints using approved procedures, coordinating with clinical and laboratory owners if the device supports patient-care operations.

How can teams verify that laboratory results were not altered?

Have authorized laboratory and technical personnel reconcile the source LIS records with available outbound messages, interface-engine logs, acknowledgments, and EHR results for the affected time period. Compare relevant patient and specimen identifiers, accessions, tests, values, units, flags, timestamps, and amendments. Investigate missing, duplicated, delayed, rejected, or inconsistent results, and document the review. If evidence is incomplete, treat integrity as unresolved rather than assuming results are unaffected.

When should clinical downtime procedures be activated?

Activate them when the incident makes a system or result pathway unreliable or unavailable in a way that could affect safe or timely patient care. Laboratory and clinical leaders should decide based on operational impact, follow the organization’s approved downtime plan, and track results and actions that must be reconciled after recovery.